Combination treatment with oxaliplatin and mangiferin causes increased apoptosis and downregulation of NFKB in cancer cell lines

African Journal of Traditional, Complementary and Alternative Medicines

Volumn 8, Issue 2, 2011, Pages 177-184

  du Plessis Stoman, D ^a   du Preez, J G H ^a   van de Venter, M ^a  

^a NELSON MANDELA METROPOLITAN UNIVERSITY   (South Africa)

Author keywords

Apoptosis; Combination treatment; Drug resistance; Mangiferin; Oxaliplatin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE 3; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANGIFERIN; OXALIPLATIN; TRYPAN BLUE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER RESISTANCE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL STRAIN HT29; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA FRAGMENTATION; DOSE RESPONSE; DOWN REGULATION; DRUG EFFICACY; DRUG POTENTIATION; DRUG RESISTANCE; ENZYME ACTIVATION; ENZYME ASSAY; HELA CELL; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; STAINING;

EID: 79953214983     PISSN: 01896016     EISSN: 01896016     Source Type: Journal    
DOI: 10.4314/ajtcam.v8i2.63206     Document Type: Article

References (28)

1. Baldwin, A.S. (2001). Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. Journal of Clinical Investigation, 107, 241-246.
2. Bhattacharya, S. K, Sanyal, A. K and Ghosal, S. (1972). Monoamine oxidase-inhibiting activity of mangiferin isolated from Canscora decussate. Naturwissenschaften, 59, 651.
3. Drisko, J. A, Chapman, J. and Hunter, V.J. (2003a). The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer. Journal of the American College of Nutrition, 22:118-123.
4. Drisko, J.A., Chapman, J. and Hunter, V.J. (2003b). The use of antioxidant therapies during chemotherapy. Gynecol. Oncol., 88, 434-439.
5. Duncan, A.C., Jager, A.K. and van Staden, J. (1999). Screening of Zulu medicinal plants for angiotensin converting enzyme (ACE) inhibitors. Journal of Ethnopharmacology, 68, 63-70.
6. Fujie, Y., Yamamoto, H., Ngan, C.Y., Takagi, A., Hayashi, T., Suzuki, R., Ezumi, K., Takemasa, I., Ikeda, M., Sekimoto, M., Matsuura, N. and Monden, M. (2005). Oxaliplatin, a Potent Inhibitor of Survivin, Enhances Paclitaxel-induced Apoptosis and Mitotic Catastrophe in Colon Cancer Cells. Japanese Journal of Clinical Oncology, 35, 453-463.
7. Gonzalez, V.M., Fuertes, M.A., Alonso, C. and Perez, J.M. (2001). Is Cisplatin-Induced Cell Death Always Produced by Apoptosis. Molecular Pharmacology, 59, 657-663.
8. Kwon, H.J., Hong, Y.K., Kim, K.H., Han, C.H., Cho, S.H., Choi, J.S. and Byung-Woo, K. (2005). Methanolic extracts of Pterocarpus santalinus induces apoptisis in HeLa cells. Journal of Ethnopharmacology, 105, 229-234.
9. Lawenda, B.D., Kelly, K.M., Ladas, E.J., Sagar, S.M., Vickers, A. and Blumberg, J.B. (2008). Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? Journal of the national cancer institute, 100, 773-783.
10. Lee, T.L., Yeh, J., Friedman, J., Yan, B., Yang, X., Yeh, N.T., van Waes, C. and Chen, Z. (2008). A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas. International Journal of Cancer, 122, 1987-1998.
11. Leiro, J., Arranza, J.A., Yanez, M., Ubeira, F.M., Sanmarti{dotless}n, M.L. and Orallo, F. (2004). Expression profiles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin. International Immunopharmacology, 4, 763-778.
12. Mabuchi, S., Ohmichi, M., Nishio, Y., Hayasaka, T., Kimura, A., Ohta, T., Saito, M., Kawagoe, J., Takahashi, K., Yada-Hashimoto, N., Sakata, M., Motoyama, T., Kurachi, H., Tasaka, K. and Murata, Y. (2004). Inhibition of NFkB increases the efficacy of Cisplatin in in vitro and in vivo ovarian cancer models. The Journal of Biological Chemistry, 10, 1-39.
13. Marnewick, J., Gelderblom, W.C.A. and Joubert, E. (2000). An investigation on the antimutagenic properties of South African herbal teas. Mutation Research, 471, 157-166.
14. Marnewick, J.L., Batenburg, W., Swart, P., Joubert, E., Swanevelder, S., Swart, P. and Gelderblom, W.C.A. (2004). Ex vivo modulation of chemical-induced mutagenesis by subcellular liver fractions of rats treated with rooibos (Aspalathus linearis) tea, honeybush (Cyclopia intermedia) tea, as well as green and black (Camellia sinensis) teas. Mutation Research, 558, 145-154.
15. Marnewick, J., Joubert, E., Josepha, S., Swanevelder, S., Swart, P. and Gelderblom, W. (2005). Inhibition of tumour promotion in mouse skin by extracts of rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia), unique South African herbal teas. Cancer Letters, 224, 193-202.
16. Martin, A.G., Lockwood, G.F., Greenslade, D., Brienza, S., Bayssas, M. and Gamelin, E. (2000). Clinical Pharmacokinetics of Oxaliplatin: A Critical Review. Clinical Cancer Research, 6, 1205-1218.
17. Muruganandan, S., Srinivasan, K., Gupta, S., Gupta, P.K. and Lal, J. (2005). Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. Journal of Ethnopharmacology, 97, 497-501.
18. Nadiminty, N., Lou, W., Lee, S.O., Lin, X., Trump, D.L. and Gao, A.C. (2006). Stat3 activation of NF-κB p100 processing involves CBP/ p300-mediated acetylation. PNAS, 103, 7264-7269.
19. Parker, S.H., Tong, T., Bolden, S. and Wingo, P.A. (1997). Cancer Statistics, 1997. CA Cancer J Clin, 47, 5-27.
20. Paul, A.T., Gohil, V.M. and Bhutani, K.K. (2006). Modulating TNF-α signaling with natural products. Drug Discovery Today, 11, 725-732.
21. Perkins, N. D. (2000). The Rel/NF-kB family: Friend and foe. TIBS 25:434-440.
22. Perkins, N. D. (2004). NF-kB: tumor promoter or suppressor? TRENDS in Cell Biology 14:64-69.
23. Sadler, P.J. and Guo, Z. (1998). Metal complexes in medicine: Design and mechanism of action. Pure and Applied Chemistry, 70, 863-971.
24. Sarkar, A., Sreenivasan, Y., Ramesh, G.T. and Manna, S.K. (2004). β-D-Glucoside Suppresses Tumor Necrosis Factor-induced Activation of Nuclear Transcription Factor κB but Potentiates Apoptosis. Journal of Biological Chemistry, 279, 33768-33781.
25. Sergent, C., Franco, N., Chapusot, C., Lizard-Nacol, S., Isambert, N., Correia, M. and Chauffert, B. (2002). Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins. Cancer Chemotherapy Pharmacology, 49, 445-452.
26. Walker, E.M. and Walker, S.M. (1999). Evolution of chemotherapy with platinum compounds. Annals of Clinical and Laboratory Science, 29, 263-274.
27. Wong, A. and Cortopassi, J.A. (2002). High-throughput measurement of mitochondrial membrane potential in a neural cell line using a fluorescence plate reader. Biochemical and Biophysical Research Communications, 298, 750-754.
28. Yang, X., Sladek, T.L., Liu, X., Butler, B.R., Froelich, C.J. and Thor, A.D. (2001). Reconstitution of Caspase 3 Sensitizes MCF-7 Breast Cancer Cells to Doxorubicin-and Etoposide-induced Apoptosis. Cancer Research, 61, 348-354.